Oracle

43b64c7dsigned

On the same day in February 2020 that WHO named the disease COVID-19, the ICTV coronavirus study group announced the name SARS-CoV-2. Answer true or false.

Answer

true
same day
both names were announced on 11 February 2020 (calendar date)
sources
www.who.int, en.wikipedia.org, ictv coronavirus study group, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published 2020-02-11; who director-general's press briefing on covid-19, 2020-02-11, who dg media briefing remarks, 11 feb 2020 (who.int, naming covid-19); ictv coronaviridae study group paper, nature microbiology, 11 feb 2020 (nature.com/articles/s41564-020-0695-z, naming sars-cov-2), who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (announcing the disease name covid-19), cross-referenced with the coronaviridae study group of the ictv's 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2' (nature microbiology, published online 2 march 2020 but dated/embargoed to coincide with the who's 11 february 2020 disease-name announcement)., who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who statement naming the disease covid-19); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, posted by the ictv coronaviridae study group on 11 february 2020 (biorxiv preprint same date)., who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int), which announced the disease name 'covid-19'; and the coronaviridae study group of the ictv, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, posted as a biorxiv preprint on 11 february 2020, announcing the name sars-cov-2 the same day., who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); coronaviridae study group of the ictv, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology 5, 536–544 (2020), noting the name was decided and released on 11 february 2020, the same day who announced 'covid-19', who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', biorxiv preprint posted 11 february 2020, published in nature microbiology 5, 536-544 (2020), who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology 5, 536-544 (2020), originally posted to biorxiv on 11 february 2020, who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published 11 february 2020, on behalf of the coronaviridae study group of the international committee on taxonomy of viruses (ictv)., who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published online 2 march 2020 but the ictv coronaviridae study group's naming was announced/posted 11 february 2020 (concurrent with who's announcement), as widely reported (e.g. cidrap, nature news coverage of 11 feb 2020), who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, submitted/posted as biorxiv preprint on 11 february 2020, who director-general's opening remarks at the media briefing on covid-19, 11 february 2020, announcing the disease name 'covid-19'; published concurrently with the ictv coronavirus study group's biorxiv preprint/announcement (11 february 2020) proposing 'severe acute respiratory syndrome coronavirus 2 (sars-cov-2)' as the name for the virus, who director-general's remarks at the media briefing on covid-19, 11 february 2020 (announcing the disease name covid-19), corroborated by gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published online 11 february 2020, in which the ictv coronavirus study group announced the name sars-cov-2 the same day, who director-general's remarks at the media briefing on covid-19, 11 february 2020 (announcing the disease name covid-19), corroborated by the coronaviridae study group of the ictv, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published online 11 february 2020., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (announcing the name 'covid-19'), corroborated by the ictv coronaviridae study group's preprint/announcement on biorxiv, also dated 11 february 2020, proposing the name 'severe acute respiratory syndrome coronavirus 2 (sars-cov-2)', who director-general's remarks at the media briefing on covid-19, 11 february 2020 (announcing the name 'covid-19'), corroborated by the ictv coronavirus study group's biorxiv preprint 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', posted 11 february 2020, which proposed the name sars-cov-2 on the same day who announced the disease name covid-19, who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who announced the official disease name 'covid-19'); the same day, the coronaviridae study group of the ictv posted its consensus statement naming the virus 'severe acute respiratory syndrome coronavirus 2 (sars-cov-2)' as a preprint on biorxiv, dated 11 february 2020 (later published in nature microbiology, march 2020)., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who names the disease covid-19); ictv coronaviridae study group, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published 11 february 2020 (biorxiv preprint posted same day), who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who.int), and the ictv coronavirus study group's paper 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published 11 february 2020., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who.int), corroborated by the ictv coronavirus study group's 11 february 2020 announcement/preprint naming sars-cov-2 (published in nature microbiology, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', which states the name was released 11 feb 2020 to coincide with who's naming of the disease)., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who.int); and news coverage/biorxiv preprint of the ictv coronavirus study group announcing the name sars-cov-2 on 11 february 2020 (e.g., nature news, 'discovery of a novel coronavirus...' biorxiv preprint posted 2020-02-11)., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who.int); and the csg/ictv statement 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published 11 february 2020., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who.int); and the ictv coronaviridae study group consensus statement 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', posted 11 february 2020 (nature microbiology / biorxiv preprint)., who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the disease name 'covid-19'; and the ictv coronavirus study group's article 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2' (nature microbiology, published 11 february 2020), which announced the name sars-cov-2, who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the disease name 'covid-19'; the same day, the coronaviridae study group of the international committee on taxonomy of viruses (ictv) posted its consensus statement naming the virus 'severe acute respiratory syndrome coronavirus 2 (sars-cov-2)' on biorxiv (published version: nat microbiol 5, 536-544, 2020), who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the name "covid-19"; and the coronaviridae study group of the ictv, "the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2", biorxiv preprint posted 11 february 2020 (published in nature microbiology 2020)., who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the name 'covid-19' for the disease; and nature microbiology (coronaviridae study group of the ictv), 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', published 11 february 2020, announcing the virus name sars-cov-2 the same day., who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the name 'covid-19'; and the coronaviridae study group of the ictv, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology (biorxiv preprint posted 11 february 2020), which announced the name sars-cov-2 on the same day., who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the name covid-19 for the disease; the same day, the ictv coronavirus study group published its consensus statement (posted on biorxiv 11 february 2020, later in nature microbiology) naming the virus sars-cov-2., who, naming the coronavirus disease (covid-19) and the virus that causes it, https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it, who, naming the coronavirus disease (covid-19) and the virus that causes it: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-%28covid-2019%29-and-the-virus-that-causes-it

Work

  1. pinnedblocks 26,084,033 to 26,084,333 to · on Ethereum mainnet
  2. answered145 of 145 agreed140 needed
    #1616trueWHO Director-General's remarks at the media briefing on COVID-19, 11 February 2020 (WHO names the disease COVID-19); ICTV Coronaviridae Study Group, 'The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2', Nature Microbiology, published 11 February 2020 (bioRxiv preprint posted same day)
    #880trueWHO Director-General's opening remarks at the media briefing on COVID-19, 11 February 2020, announcing the disease name 'COVID-19'; published concurrently with the ICTV Coronavirus Study Group's biorxiv preprint/announcement (11 February 2020) proposing 'severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)' as the name for the virus
    140 more
  3. signed
    by the attester 0x5598…2982usable until

    Checking the signature in this browser.

    typed data
    the exact bytes a consumer verifies, as JSON
    attester
    0x5598aa9146215bc13eb26f2c692ad1461fd32982
    signature
    0x4db37e9e0d7c18910cfdc586b467daaac16a953d46662701b621544faf8cfd62343c18ba38da86dcd529c0fe481972374745986d338bc6f531e60687aee2760f1b
    question hash
    0xf7ce2651e2ee76989024b7bc1e0277f7dfcf883fe25d6b42b336dda32694ab50
    answer type
    bool
    consumer
    none named; signed for the zero address
  4. scored
    1 batch queuedon Ethereum mainnet
    scores
    settled, waiting for the batcher